| Metric | შპს ნიუ ფარმა NEW PHARMA | შპს სოკარ ენერჯი ჯორჯია |
|---|---|---|
| Growth | ||
| Revenue | ₾883₾4.1m | ₾2.05bn₾2.35bn |
| Revenue growth | -100.0% | -12.7% |
| Profitability | ||
| EBITDA | -₾262k-₾476k | ₾210.3m₾234.7m |
| EBITDA margin | -29687.2%-11.6% | 10.3%10.0% |
| Net profit | -₾258k-₾726k | ₾101.6m₾176.9m |
| Net margin | -29249.2%-17.7% | 4.9%7.5% |
| Balance sheet | ||
| Total assets | ₾83k₾1.4m | ₾1.40bn₾1.43bn |
| Total equity | -₾780k-₾522k | ₾64.4m-₾37.1m |
| ROE | — | 157.6% |